Prostate Cancer
SANDSTORM - Sequencing of ADT with radiotherapy
-TN23-GU.png)
In a pooled analysis of 12 randomised trials #SANDSTORM, to address the sequencing of androgen-deprivation therapy (ADT) with radiotherapy, concurrent/adjuvant...
MITNEC-A1 study - 18F-sodium fluoride PET–CT vs 99mTc bone scintigraphy with SPECT
.png)
In multicenter, phase 3 #MITNEC-A1 study, 18F-sodium fluoride PET–CT was compared to 99mTc bone scintigraphy with SPECT in patients with...
MITNEC-A1 study
In multicenter, phase 3 #MITNEC-A1 study, 18F-sodium fluoride PET–CT was compared to 99mTc bone scintigraphy with SPECT in patients with...
PRESTO trial
ADT Intensification might be the resort to delay biochemical progression in High risk biochemical relapse (BCR) #prostate cancer after Radical...
STAMPEDE trial
The combination of #Enzalutamide (ENZ) Plus #Abiraterone Acetate and Prednisolone (AAP) is NOT Recommended for #mHSPC based on the recent...
RADICALS-HD trial
First results of the RADICALS-HD trial presented by Dr. Chris Parker demonstrated that in patients having post-operative radiotherapy after...
CABASTY trial
In CABASTY trial presented by Dr. Stephane Oudard, #Cabazitaxel 16 mg/m2 every 2 weeks (CBZ q2w) + G-CSF was compared...
KEYLYNK-010 trial
In the randomized KEYLYNK-010 study presented by Dr. Evan Yu, #Pembrolizumab + #olaparib (P+O) failed to improve rPFS or OS...
FDA approval of bevacizumab biosimilar
On September 28th 2022, the FDA has approved Celltrion’s #bevacizumab biosimilar (bevacizumab-adcd) in six types of cancers which are: metastatic...
.png)